Furthermore, we discovered that increased BAMBI expression was negatively correlated with FEV1% in COPD patients, indicating that BAMBI may be a therapeutic target for COPD and improving our understanding of the pathogenesis of COPD. This evidence concerns the gene BAMBI and chronic obstructive pulmonary disease.